NASDAQ:JANX

Janux Therapeutics Stock Forecast

etoro logo Buy JANX
*Your capital is at risk
$15.33
-0.390 (-2.48%)
At Close: Jul 24, 2026
AI Analysis AI Analysis of JANX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add JANX to Watchlist?
Some Reasons Why To Add JANX:
  • Low bankruptcy risk (Altman Z-Score: 6.84)
  • Consistently positive technical signals over the last month
  • Highly efficient cash conversion (101% FCF/OCF ratio)
PDF

Janux Therapeutics, Inc. stock price ended at $15.33 on Friday, after losing 2.48%
(Updated on Jul 24, 2026)

Buy or Hold candidate since Jul 02, 2026 Loss -1.35%

The Janux Therapeutics, Inc. stock price fell by -2.48% on the last day (Friday, 24th Jul 2026) from $15.72 to $15.33. During the last trading day the stock fluctuated 4.10% from a day low at $15.24 to a day high of $15.87. The price has fallen in 6 of the last 10 days and is down by -6.52% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -404 thousand shares and in total, 527 thousand shares were bought and sold for approximately $8.09 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.55% during the next 3 months and, with a 90% probability hold a price between $15.86 and $19.24 at the end of this 3-month period.

JANX Signals & Forecast

The Janux Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $15.87. On a fall, the stock will find some support from the long-term average at approximately $15.00. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -8.48%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Janux Therapeutics, Inc. stock

Janux Therapeutics, Inc. finds support from accumulated volume at $14.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.625 between high and low, or 4.10%. For the last week, the stock has had daily average volatility of 3.53%.

Our recommended stop-loss: $14.48 (-5.55%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 11 days ago.)

Trading Expectations (JANX) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Janux Therapeutics, Inc. to open at $15.48, and during the day (based on 14 day Average True Range), to move between $15.02 and $15.64, which gives a possible trading interval of +/-$0.617 (+/-4.11%) up or down from last closing price. If Janux Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 4.11% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $14.94 (2.54%) than the resistance at $16.15 (5.35%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Janux Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Janux Therapeutics, Inc. stock to perform well in the short-term.

Current score: 2.103 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $15.48 ( 0.97%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

JANX Performance

Trading levels for JANX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 16.10 5.05%
R2 15.86 3.49%
R1 15.72 2.53%
Price 15.33
S1 15.24 -0.590%
S2 15.09 -1.55%
S3 14.85 -3.11%

Accumulated Volume Support & Resistance Levels

Level Price
R3 16.66 8.68%
R2 16.26 6.07%
R1 16.15 5.35%
Price 15.33
S1 14.94 -2.54%
S2 14.58 -4.89%
S3 13.81 -9.92%

FAQ

What is the symbol for Janux Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Janux Therapeutics, Inc. is JANX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Janux Therapeutics, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Janux Therapeutics, Inc. stock to perform well in the short-term.

How to buy Janux Therapeutics, Inc. Stock?
Janux Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Janux Therapeutics, Inc. Stock.

What's the current price of Janux Therapeutics, Inc. Stock?
As of the end of day on the Jul 24, 2026, the price of an Janux Therapeutics, Inc. (JANX) share was $15.33.

What is the 52-week high and low for Janux Therapeutics, Inc. Stock?
The 52-week high for Janux Therapeutics, Inc. Stock is $35.25 and the 52-week low is $12.13.

What is the market capitalization of Janux Therapeutics, Inc. Stock?
As of the Jul 24, 2026, the market capitalization of Janux Therapeutics, Inc. is 934.89M.

When is the next earnings date for Janux Therapeutics, Inc.?
The upcoming earnings date for Janux Therapeutics, Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT JANUX THERAPEUTICS, INC.
Janux Therapeutics
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a ...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
ROP
$331.60
10.78% Jun 24
JLL
$299.78
8.56% Jun 24
NMRK
$15.02
2.46% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE